Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety”

Detalles Bibliográficos
Autores principales: Grube, Barbara, Bongartz, Udo, Alt, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227155/
https://www.ncbi.nlm.nih.gov/pubmed/28119761
http://dx.doi.org/10.1155/2016/7173896
_version_ 1782493773659373568
author Grube, Barbara
Bongartz, Udo
Alt, Felix
author_facet Grube, Barbara
Bongartz, Udo
Alt, Felix
author_sort Grube, Barbara
collection PubMed
description
format Online
Article
Text
id pubmed-5227155
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-52271552017-01-24 Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety” Grube, Barbara Bongartz, Udo Alt, Felix Evid Based Complement Alternat Med Corrigendum Hindawi Publishing Corporation 2016 2016-12-29 /pmc/articles/PMC5227155/ /pubmed/28119761 http://dx.doi.org/10.1155/2016/7173896 Text en Copyright © 2016 Barbara Grube et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Grube, Barbara
Bongartz, Udo
Alt, Felix
Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety”
title Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety”
title_full Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety”
title_fullStr Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety”
title_full_unstemmed Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety”
title_short Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety”
title_sort corrigendum to “iqp-vv-102, a novel proprietary composition for weight reduction: a double-blind randomized clinical trial for evaluation of efficacy and safety”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227155/
https://www.ncbi.nlm.nih.gov/pubmed/28119761
http://dx.doi.org/10.1155/2016/7173896
work_keys_str_mv AT grubebarbara corrigendumtoiqpvv102anovelproprietarycompositionforweightreductionadoubleblindrandomizedclinicaltrialforevaluationofefficacyandsafety
AT bongartzudo corrigendumtoiqpvv102anovelproprietarycompositionforweightreductionadoubleblindrandomizedclinicaltrialforevaluationofefficacyandsafety
AT altfelix corrigendumtoiqpvv102anovelproprietarycompositionforweightreductionadoubleblindrandomizedclinicaltrialforevaluationofefficacyandsafety

Ejemplares similares